Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725982 | SCV000340997 | uncertain significance | not provided | 2016-04-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000725982 | SCV000605432 | uncertain significance | not provided | 2023-10-18 | criteria provided, single submitter | clinical testing | The TRIP11 c.2102A>G; p.Asn701Ser variant (rs139539448), to our knowledge, is not described in the medical literature but contains an entry in ClinVar (Variation ID: 5511). It is observed in the general population at an overall frequency of 0.17% (484/282038 alleles) in the Genome Aggregation Database. The asparagine at position 701 is weakly conserved, and computational analyses predict that this variant is neutral (REVEL: 0.037). However, due to limited clinical and functional data regarding this variant, its clinical significance cannot be determined with certainty. |
Labcorp Genetics |
RCV000005846 | SCV001101898 | likely benign | Achondrogenesis, type IA | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000005846 | SCV001275251 | likely benign | Achondrogenesis, type IA | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Genome Diagnostics Laboratory, |
RCV002276533 | SCV002567053 | uncertain significance | Connective tissue disorder | 2018-11-07 | criteria provided, single submitter | clinical testing |